1-bromopropane has been researched along with Cognitive Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qiu, X; Wang, Q; Wang, S; Xu, L; Zhao, XL | 1 |
1 other study(ies) available for 1-bromopropane and Cognitive Dysfunction
Article | Year |
---|---|
NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.
Topics: Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hydrocarbons, Brominated; Inflammasomes; Male; Maze Learning; Microglia; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Nootropic Agents; Random Allocation; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spatial Memory; Specific Pathogen-Free Organisms | 2019 |